Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI

Journal of Clinical Neuroscience

Volumn 21, Issue 4, 2014, Pages 583-586

  Marques, Inês Brás ^a   Matias, Fernando ^a   Silva, Eduardo Duarte ^a   Cunha, Luis ^a   Sousa, Lívia ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Clinically isolated syndrome; Demyelinating diseases; Multiple sclerosis; Optic neuritis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMYELINATION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PAPILLEDEMA; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VISUAL ACUITY; BRAIN; DISEASE COURSE; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; VISUAL ACUITY; YOUNG ADULT;

EID: 84896097376     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.06.013     Document Type: Article

References (34)

1. L.J. Balcer Optic neuritis N Engl J Med 354 2006 1273 1280
2. E.M. Frohman, T.C. Frohman, and D.S. Zee et al. The neuro-ophthalmology of multiple sclerosis Lancet Neurol 4 2005 111 121
3. Optic Neuritis Study Group Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up Arch Neurol 65 2008 727 732
4. CHAMPS Study Group Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis Am J Ophthalmol 132 2001 463 471
5. R.W. Beck, D.L. Chandler, and S.R. Cole et al. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses Ann Neurol 51 2002 481 490
6. R.P. Kinkel, C. Kollman, and P. O'Connor et al. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event Neurology 66 2006 678 684
7. G. Comi, M. Filippi, and F. Barkhof et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study Lancet 357 2001 1576 1582
8. L. Kappos, C.H. Polman, and M.S. Freedman et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes Neurology 67 2006 1242 1249
9. G. Comi, V. Martinelli, and M. Rodegher et al. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe Study): a randomised, double blind, placebo-controlled trial Lancet 374 2009 1503 1511
10. G. Comi, N. De Stefano, and M.S. Freedman et al. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial Lancet Neurol 11 2012 33 41
11. J.I. O'Riordan, A.J. Thompson, and D.P. Kingsley et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up Brain 121 1998 495 503
12. S.P. Morrissey, D.H. Miller, and B.E. Kendall et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: a 5-year follow-up study Brain 116 1993 135 146
13. T. Korteweg, M. Tintoré, and B. Uitdehaag et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study Lancet Neurol 5 2006 221 227
14. L.D. Jacobs, S.E. Kaba, and C.M. Miller et al. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis Ann Neurol 41 1997 392 398
15. M. Söderström, Y.P. Jin, and J. Hillert et al. Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF and HLA findings Neurology 50 1998 708 714
16. P.A. Brex, O. Ciccarelli, and J.I. O'Riordan et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis N Engl J Med 346 2002 158 164
17. S.A. Morrow, J.A. Fraser, and D. Nicolle et al. Predicting conversion to MS - the role of a history suggestive of demyelination Can J Neurol Sci 37 2010 488 491
18. O. Gout, C. Lebrun-Frenay, and P. Labauge et al. Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event J Neurol Neurosurg Psychiatry 82 2011 323 325
19. C.M. Poser, D.W. Paty, and L. Scheinberg et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols Ann Neurol 13 1983 227 231
20. W.I. McDonald, A. Compston, and G. Edan et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
21. C.H. Poman, S.C. Reingold, and G. Edan et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 2005 840 846
22. C.H. Polman, S.C. Reingold, and B. Banwell et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann Neurol 69 2011 292 302
23. M. Tintoré, A. Rovira, and J. Río et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70 2008 1079 1083
24. D. Marshall Ocular manifestations of multiple sclerosis and relationship to retrobulbar neuritis Trans Am Ophthalmol Soc 48 1950 487 525
25. T.J. Martin, and J.J. Corbett Neuro-ophthalmology: the requisites 1st ed. 2000 Mosby St Lois
26. B.D. Trapp, J. Peterson, and R.M. Ransohoff et al. Axonal transection in the lesions of multiple sclerosis N Engl J Med 338 1998 278 285
27. M. Filippi, M. Bozzali, and M. Rovaris et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis Brain 126 2003 433 437
28. M.A. Rocca, D.M. Mezzapesa, and A. Falini et al. Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis Neuroimage 18 2003 847 855
29. M.P. Wattjes, M. Harzheim, and G.G. Lutterbey et al. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria J Neurol 255 2008 56 63
30. F. Costello, S. Coupland, and W. Hodge et al. Quantifying axonal loss after optic neuritis with optical coherence tomography Ann Neurol 59 2006 963 969
31. S.A. Trip, P.G. Schlottmann, and S.J. Jones et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy Neuroimage 31 2006 286 293
32. S.A. Trip, P.G. Schlottmann, and S.J. Jones et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis Ann Neurol 58 2005 383 391
33. P. Nilsson, E.M. Larsson, and P. Maly-Sundgren et al. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up J Neurol 252 2005 396 402
34. E.M. Mowry, M. Pesic, and B. Grimes et al. Clinical predictors of early second event in patients with clinically isolated syndrome J Neurol 256 2009 1061 1066